These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Brown NJ; Byiers S; Carr D; Maldonado M; Warner BA Hypertension; 2009 Sep; 54(3):516-23. PubMed ID: 19581505 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Kyrmizakis DE; Papadakis CE; Liolios AD; Karatzanis AD; Malandrakis S; Skoulakis CE; Bizakis JG; Velegrakis GA Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1416-9. PubMed ID: 15611402 [TBL] [Abstract][Full Text] [Related]
10. Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates. Millot I; Plancade D; Hosotte M; Landy C; Nadaud J; Ragot C; Graffin B; Drouet C; Kanny G Br J Anaesth; 2012 Nov; 109(5):827-9. PubMed ID: 23066003 [No Abstract] [Full Text] [Related]
11. DPP-4 inhibitors and angioedema: a cause for concern? Byrd JS; Minor DS; Elsayed R; Marshall GD Ann Allergy Asthma Immunol; 2011 May; 106(5):436-8. PubMed ID: 21530877 [No Abstract] [Full Text] [Related]
12. Iatrogenic angioedema associated with ACEi, sitagliptin, and deficiency of 3 enzymes catabolizing bradykinin. Beaudouin E; Defendi F; Picaud J; Drouet C; Ponard D; Moneret-Vautrin DA Eur Ann Allergy Clin Immunol; 2014 May; 46(3):119-22. PubMed ID: 24853572 [TBL] [Abstract][Full Text] [Related]
14. Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema? Grouzmann E; Buclin T Hypertension; 2008 Jan; 51(1):45-7. PubMed ID: 18025291 [No Abstract] [Full Text] [Related]
15. [Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema]. Nosbaum A; Bouillet L; Floccard B; Javaud N; Launay D; Boccon-Gibod I; Fain O; ; Rev Med Interne; 2013 Apr; 34(4):209-13. PubMed ID: 23380506 [TBL] [Abstract][Full Text] [Related]
16. [ACE-inhibitor-induced angioedema. The most frequent cause of oropharyngeal edema]. Leuwer A; Krause J HNO; 1998 Jan; 46(1):56-9. PubMed ID: 9539057 [TBL] [Abstract][Full Text] [Related]
17. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED. Bartal C; Zeldetz V; Stavi V; Barski L Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359 [TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Lefebvre J; Murphey LJ; Hartert TV; Jiao Shan R; Simmons WH; Brown NJ Hypertension; 2002 Feb; 39(2 Pt 2):460-4. PubMed ID: 11882590 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema. Stone C; Brown NJ Immunol Allergy Clin North Am; 2017 Aug; 37(3):483-495. PubMed ID: 28687104 [TBL] [Abstract][Full Text] [Related]
20. DPP-IV Inhibitor-Associated Angioedema in Patient With Known History of ACE Inhibitor Angioedema. Ejikeme C; Nwachukwu C; Viechweg JL; Ejikeme I; Brescia M J Investig Med High Impact Case Rep; 2021; 9():23247096211033049. PubMed ID: 34330175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]